FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norbert Vey

Research Profile

Concepts & Ideas

Procedures

Disorders

Co-author Network

Publications

TOP 3
Cecile Bally; Caroline Dartigeas; Stéphane de Botton; Benoit de Renzis; Francois Dreyfus; Jehane Fadlallah; Pierre Fenaux; Raphael Itzykson; Bruno Quesnel; Sylvain Thépot; Pascal Turlure; Norbert Vey; Lionel Adès
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Raynier Devillier; Evelyne D'Incan; Jean El-Cheikh; Anne Etienne; Catherine Faucher; Sabine Fürst; Thomas Prebet; Jérôme Rey; Didier Blaise; Aude Charbonnier; Roberto Crocchiolo; Norbert Vey
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia.
Véronique Gelsi-Boyer; Ken I Mills; Marie-Joëlle Mozziconacci; Anne Murati; Norbert Vey; Mandy Brecqueville; Nathalie Cervera; Nicholas C P Cross; Pascal Finetti; Christine Arnoulet; François Bertucci; Daniel Birnbaum
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norbert Vey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cecile Bally; Caroline Dartigeas; Stéphane de Botton; Benoit de Renzis; Francois Dreyfus; Jehane Fadlallah; Pierre Fenaux; Raphael Itzykson; Bruno Quesnel; Sylvain Thépot; Pascal Turlure; Norbert Vey; Lionel Adès
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Leukemia research 2013;37(6):637-40.
2013: Raynier Devillier; Evelyne D'Incan; Jean El-Cheikh; Anne Etienne; Catherine Faucher; Sabine Fürst; Thomas Prebet; Jérôme Rey; Didier Blaise; Aude Charbonnier; Roberto Crocchiolo; Norbert Vey
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia.
Leukemia & lymphoma 2013;54(6):1228-34.
2013: Véronique Gelsi-Boyer; Ken I Mills; Marie-Joëlle Mozziconacci; Anne Murati; Norbert Vey; Mandy Brecqueville; Nathalie Cervera; Nicholas C P Cross; Pascal Finetti; Christine Arnoulet; François Bertucci; Daniel Birnbaum
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
Haematologica 2013;98(4):576-83.
2013: Eric Jourdan; Bruno Lioure; Isabelle Luquet; Cécile Pautas; Arnaud Pigneux; Claude Preudhomme; Emmanuel Raffoux; Christian Recher; Aline Renneville; Christine Terré; Xavier Thomas; Norbert Vey; Marie C Béné; Céline Berthon; Odile Blanchet; Nicolas Boissel; Claude-Eric Bulabois; Jean-Michel Cayuela; Sylvie Chevret; Pascale Cornillet; Eric Delabesse; Jacques Delaunay; Hervé Dombret; Philippe Guardiola; Norbert Ifrah
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Blood 2013;121(12):2213-23.
2013: Roberto Crocchiolo; Raynier Devillier; Jean El-Cheikh; Benjamin Esterni; Sabine Fürst; Angela Granata; Claire Oudin; Norbert Vey; Réda Bouabdallah; Boris Calmels; Luca Castagna; Christian Chabannon; Didier Blaise
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases.
Cancer 2013;119(5):986-92.
2013: Norbert Vey
Targeting age-related changes in the biology of acute myeloid leukemia: is the patient seeing the progress?.
Interdisciplinary topics in gerontology 2013;38():73-84.
2013: Jean El-Cheikh; Catherine Faucher; Sabine Furst; Angela Granata; Patrick Ladaique; Claude Lemarie; Claire Oudin; Norbert Vey; Reda Bouabdallah; Boris Calmels; Luca Castagna; Christian Chabannon; Roberto Crocchiolo; Raynier Devillier; Didier Blaise
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.
Experimental hematology 2013;41(1):17-27.
2012: Romain Guièze; Jean-Luc Harousseau; Chantal Himberlin; Norbert Ifrah; Bruno Lioure; Arnaud Pigneux; Christian Recher; Pascal Turlure; Norbert Vey; Marie C Béné; Odile Blanchet; Caroline Bonmati; Didier Bouscary; Claude-Eric Bulabois; Patrice Chevallier; Pascale Cornillet-Lefebvre; Martine Delain; Francois Dreyfus; Nathalie Fegueux
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
American journal of hematology 2012;87(12):1052-6.
2012: Norbert Vey; Thomas Prebet; François Romagne; Pascale Andre; Don Benson; Nicolas Boissel; Dominique Bordessoule; Jean-Henri Bourhis; Aude Charbonnier; Herve Dombret; Anne Etienne; Daniel Olive
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.
Blood 2012;120(22):4317-23.
2012: Cecile Borel; Valérie Cances-Lauwers; Marie Agnes Collonges Rames; Nicole Dastugue; Eric Delabesse; Nathalie Gachard; Faezeh Legrand; Eric Lippert; Marie-Joëlle Mozziconacci; Francine Mugneret; Arnaud Pigneux; Thomas Prebet; Jean Philippe Rault; Pascaline Talmant; Sylvie Taviaux; Norbert Vey; Sorin Visanica; Christian Bastard; Christian Récher
PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients.
Leukemia research 2012;36(11):1365-9.
2012: Thomas Prébet; Jerome Rey; Christine Arnoulet; Aurélie Autret; Didier Blaise; Aude Charbonnier; Evelyne D'incan; Anne Etienne; Sabine Fürst; Estelle Jean; Norbert Vey
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction.
Leukemia & lymphoma 2012;53(11):2186-91.
2012: Jean M Brunel; Thomas Prebet; Audrey Restouin; Chanaz Salmi-Smail; Norbert Vey; Yves Collette
Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic composition.
Anti-cancer agents in medicinal chemistry 2012;12(7):801-6.
2012: Mandy Brecqueville; Nadine Carbuccia; Nathalie Cervera; Emilie Coppin; Pascal Finetti; Véronique Gelsi-Boyer; Olivier Gisserot; Marie-Joëlle Mozziconacci; Jérôme Rey; Borhane Slama; Denis Verrot; Norbert Vey; Christine Arnoulet; François Bertucci; Daniel Birnbaum; Anne Murati
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Genes, chromosomes & cancer 2012;51(8):743-55.
2012: Shanti Natarajan-Amé; Sophie Park; C Ravoet; Aline Schmidt; Aspasia Stamatoullas; Norbert Vey; Lionel Ades; Elisabeth Berger; Dominique Bordessoule; Thorsten Braun; Jean-Yves Cahn; Aude Charbonnier; Marie-Pierre Chaury; Stephane Cheze; Francois Dreyfus; Gabriel Etienne; Pierre Fenaux; Agnès Guerci-Bresler; Laurence Legros
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
British journal of haematology 2012;158(2):232-7.
2012: Raynier Devillier; Véronique Gelsi-Boyer; Daniel Birnbaum; Mandy Brecqueville; Nadine Carbuccia; Anne Murati; Norbert Vey; Marie-Joëlle Mozziconacci
Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
American journal of hematology 2012;87(7):659-62.
2012: Cecile Bally; Andre Baruchel; Yves Bertrand; Bruno Cassinat; Christine Chomienne; Herve Dombret; Jehane Fadlallah; Pierre Fenaux; Agnes Guerci; Nadia Idres; Thierry Leblanc; Guy Leverger; Emmanuel Raffoux; Christian Recher; Alain Robert; Miguel Sanz; Xavier Thomas; Norbert Vey; Lionel Adès
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1641-6.
2012: Julie Gertner-Dardenne; Eloïse Kochbati; Emilie Mamessier; Rémy Castellano; Aude Charbonnier; Yves Collette; Anne Etienne; Slaveia Garbit; Norbert Vey; Daniel Olive
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(9):4701-8.
2012: R Devillier; Jean El-Cheikh; Benjamin Esterni; A Etienne; Catherine Faucher; Sabine Fürst; Thomas Prebet; Norbert Vey; L Castagna; Christian Chabannon; R Crocchiolo; Didier Blaise
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Bone marrow transplantation 2012;47(5):639-45.
2012: Frederik Damm; Stéphane de Botton; Véronique Della Valle; François Dreyfus; Michaëla Fontenay; Véronique Gelsi-Boyer; Agnes Guerci-Bresler; Claire Hidalgo-Curtis; Olivier Kosmider; Michael A Morgan; Thomas Prébet; Claude Preudhomme; Aline Renneville; Aline Schmidt-Tanguy; Laurianne Scourzic; Bohrane Slama; Aspasia Stamatoullas-Bastard; Norbert Vey; Olivier A Bernard; Odile Beyne-Rauzy; Daniel Birnbaum; Nadine Carbuccia; Virginie Chesnais; Lucile Couronné; Nicholas C P Cross
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.
Blood 2012;119(14):3211-8.
2012: R Itzykson; Laurence Legros; Jean-Valère Malfuson; C Salanoubat; Anne-Laure Taksin; S Thépot; Pascal Turlure; Norbert Vey; Lionel Ades; S Ame; C Berthon; Odile Beyne-Rauzy; Simone Boehrer; Y Chelgoum; François Dreyfus; Pierre Fenaux; Claude Gardin; F Isnard
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Leukemia research 2012;36(4):397-400.
2012: Catherine Faucher; Dominique Genre; A G Le Corroller Soriano; D Maraninchi; M Michallet; J P Moatti; Mohamad Mohty; Anne-Marie Stoppa; Norbert Vey; P Viens; J O Bay; C Chabannon; Benjamin Esterni; Didier Blaise
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs.
Bone marrow transplantation 2012;47(4):549-55.
2012: Julien Mancini; Isabelle Pellegrini; Norbert Vey; Lise-Marie Billard-Daufresne; Christian Chabannon; Claire Julian-Reynier
[Perception by cancer patients of biomedical research in the era of large-scale biobanking].
Médecine sciences : M/S 2012;28 Spec No 1():28-32.
2012: David Sibon; Bohrane Slama; Norbert Vey; Eric Wattel; Anne Banos; Fiorenza Baracco; Caroline Besson; Michel Blanc; Giovanna Cannas; Selim Corm; Pierre Fenaux; Hervé Perrier; Thomas Prebet
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents.
British journal of haematology 2012;156(5):619-25.
2012: Lionel Adès; Anne Banos; Michel Blanc; Didier Bouscary; Agnès Guerci Bresler; Marie-Paule Cabrol; Sylvie Chevret; Jacques Delaunay; Alain Delmer; François Dreyfus; Virginie Eclache; Charikleia Kelaidi; Thierry Lamy; Fabien Le Bras; Marie Sebert; Pascal Turlure; Norbert Vey; Sorin Visanica; Eric Wattel; Pierre Fenaux
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies.
Haematologica 2012;97(2):213-8.
2011: Sophie Park; C Rose; Rosa Sapena; B Slama; Aspasia Stamatoullas; Gérard Tertian; D Vassilieff; Norbert Vey; Odile Beyne-Rauzy; Dominique Bordessoule; Stéphane Cheze; Pierre Fenaux; Agnès Guerci; C Kelaidi; Shanti Natarajan-Amé; François Dreyfus
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.
Leukemia research 2011;35(11):1530-3.
2011: Thorsten Braun; Benoit de Renzis; François Dreyfus; Nathalie M Droin; Pierre Fenaux; Michaëla Fontenay; Claude Gardin; Raphael Itzykson; Bertrand Joly; Ingrid Lafon; Kamel Laribi; Guillaume Meurice; Cédric Oréar; Claude Preudhomme; Christian Recher; Aline Renneville; Bruno Royer; Laurence Sanhes; Eric Solary; Andrea Toma; Anne Vekhoff; Norbert Vey; Lionel Ades; Krimo Bouabdallah
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.
Blood 2011;118(14):3824-31.
2011: Thomas Prébet; Bruno Quesnel; Odile Beyne Rauzy; Christian Recher; Sylvain Thepot; Lionel Adès; C L Beach; François Dreyfus; Benjamin Esterni; Pierre Fenaux; Claude Gardin; Steven D Gore; Raphael Itzykson; Norbert Vey
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3322-7.
2011: Aurore Perrot; Arnaud Pigneux; Edouard Randriamalala; Christian Recher; Norbert Vey; Francis Witz; Carole Barin; Marie C Béné; Christian Berthou; Jean-Yves Cahn; Jacques Delaunay; Nathalie Fegueux; Philippe Guardiola; Jean-Luc Harousseau; Chantal Himberlin; Norbert Ifrah; Bruno Lioure; Isabelle Luquet; Francine Mugneret; Mario Ojeda-Uribe
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities.
Blood 2011;118(3):679-85.
2011: R Itzykson; O Kosmider; Véronique Mansat-De Mas; Claude Preudhomme; B Quesnel; S Raynaud; Norbert Vey; L Adès; Odile Beyne-Rauzy; T Cluzeau; François Dreyfus; Pierre Fenaux; Michaëla Fontenay; Véronique Gelsi-Boyer
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
Leukemia 2011;25(7):1147-52.
2011: R Itzykson; B Quesnel; Christian Recher; S Thépot; Pascal Turlure; Norbert Vey; L Adès; Odile Beyne-Rauzy; S Boehrer; François Dreyfus; Virginie Eclache; Pierre Fenaux; Claude Gardin
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine.
Leukemia 2011;25(7):1207-9.
2011: Thorsten Braun; Bruno Cassinat; Sylvie Castaigne; Valérie Coiteux; Stéphane de Botton; François Dreyfus; Virginie Eclache; Pierre Fenaux; Michaela Fontenay; Khaled Guenda; Agnès Guerci; Anne Lazareth; Geneviève Leroux; Sophie Park; Rosa Sapena; Aspasia Stamatoullas; Anne-Laure Taksin; Christine Terré; Norbert Vey; Odile Beyne-Rauzy; Dominique Bordessoule; Lionel Adès
Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
Leukemia research 2011;35(7):863-7.
2011: L Castagna; Jean El-Cheikh; Benjamin Esterni; Catherine Faucher; Sabine Fürst; N Marchetti; Mohamad Mohty; Anne-Marie Stoppa; Norbert Vey; Reda Bouabdallah; Didier Blaise
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT.
Bone marrow transplantation 2011;46(7):1000-5.
2011: Mélanie Bonnet; Julie Di Cristofaro; Willem A Dik; Christine Formisano-Tréziny; Chantal Fossat; Jean Gabert; Lucie Hernandez; Anton W Langerak; Marie Loosveld; Elizabeth Macintyre; Emilie Mamessier; Gérard Michel; Bertrand Montpellier; Ester Morgado; Jean-Marc Navarro; Dominique Payet-Bornet; Christophe Picard; Thomas Prebet; Benoit Quilichini; Sandrine Roulland; Jean Soulier; Norbert Vey; Vahid Asnafi; Claude BAGNIS; Bertrand Nadel
Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.
Blood 2011;117(24):6650-9.
2011: Thomas Prebet; Anne Etienne; Raynier Devillier; Emilie Romeo; Aude Charbonnier; Evelyne D'incan; Benjamin Esterni; Christine Arnoulet; Didier Blaise; Norbert Vey
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study.
Cancer 2011;117(5):974-81.
2011: Thomas Prebet; Norbert Vey
Vorinostat in acute myeloid leukemia and myelodysplastic syndromes.
Expert opinion on investigational drugs 2011;20(2):287-95.
2011: Julien Mancini; Isabelle Pellegrini; Frédéric Viret; Norbert Vey; Lise-Marie Daufresne; Christian Chabannon; Claire Julian-Reynier
Consent for biobanking: assessing the understanding and views of cancer patients.
Journal of the National Cancer Institute 2011;103(2):154-7.
2011: Raphael Itzykson; Sylvain Thépot; Bruno Quesnel; François Dreyfus; Odile Beyne-Rauzy; Pascal Turlure; Norbert Vey; Christian Recher; Caroline Dartigeas; Laurence Legros; Jacques Delaunay; Célia Salanoubat; Sorin Visanica; Aspasia Stamatoullas; Francoise Isnard; Anne Marfaing-Koka; Stephane de Botton; Youcef Chelghoum; Anne-Laure Taksin; Isabelle Plantier; Shanti Ame; Simone Boehrer; Claude Gardin; C L Beach; Lionel Adès; Pierre Fenaux
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Blood 2011;117(2):403-11.
2010: Norbert Vey; Aude Charbonnier
[Current management of myelodysplastic syndromes].
La Revue du praticien 2010;60(10):1416-9.
2010: Didier Blaise; Laure Farnault; Catherine Faucher; Nicholas Marchetti; Sabine Fürst; Jean El-Cheikh; Patrick Ladaique; Norbert Vey; Reda Bouabdallah; Anne-Marie Stoppa; Claude Lemarie; Boris Calmels; Thomas Prebet; Luca Castagna; Christian Chabannon; Mohamad Mohty; Benjamin Esterni
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Experimental hematology 2010;38(12):1241-50.
2010: Véronique Gelsi-Boyer; Virginie Trouplin; Julien Roquain; José Adélaïde; Nadine Carbuccia; Benjamin Esterni; Pascal Finetti; Anne Murati; Christine Arnoulet; Hacène Zerazhi; Hacène Fezoui; Zoulika Tadrist; Meyer Nezri; Max Chaffanet; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
British journal of haematology 2010;151(4):365-75.
2010: Sophie Park; Charikleia Kelaidi; Rosa Sapena; Dominique Vassilieff; Odile Beyne-Rauzy; Valérie Coiteux; Norbert Vey; C Ravoet; Stéphane Cheze; Christian Rose; Laurence Legros; Aspasia Stamatoullas; Martine Escoffre-Barbe; Agnès Guerci; Marie-Pierre Chaury; Pierre Fenaux; François Dreyfus
Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients.
Leukemia research 2010;34(11):1430-6.
2010: T Prébet; R Devillier; Sabine Fürst; Norbert Vey; Didier Blaise
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning.
Bone marrow transplantation 2010;45(10):1574-5.
2010: Thomas Prebet; Anne-Catherine Lhoumeau; Christine Arnoulet; Anaïs Aulas; Sylvie Marchetto; Stéphane Audebert; Francesca Puppo; Christian Chabannon; Danielle Sainty; Marie-Josée Santoni; Michael Sebbagh; Virginia Summerour; Yannick Huon; Won-Sik Shin; Seung-Taek Lee; Benjamin Esterni; Norbert Vey; Jean-Paul Borg
The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Blood 2010;116(13):2315-23.
2010: Julien Rocquain; Véronique Gelsi-Boyer; José Adélaïde; Anne Murati; Nadine Carbuccia; Norbert Vey; Daniel Birnbaum; Marie-Joëlle Mozziconacci; Max Chaffanet
Alteration of cohesin genes in myeloid diseases.
American journal of hematology 2010;85(9):717-9.
2010: José Adélaïde; Véronique Gelsi-Boyer; J Rocquain; Nadine Carbuccia; D J Birnbaum; Pascal Finetti; François Bertucci; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum; Max Chaffanet
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies.
Leukemia 2010;24(8):1539-41.
2010: P Chevallier; L Fornecker; Bruno Lioure; M C Béné; A Pigneux; C Recher; Brigitte Witz; N Fegueux; Claude-Eric Bulabois; S Daliphard; D Bouscary; Norbert Vey; Martine Delain; Jacques-Olivier Bay; P Turlure; Marc Bernard; C Himberlin; I Luquet; Norbert Ifrah; Jean-Luc Harousseau
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
Leukemia 2010;24(7):1380-5.
2010: Norbert Vey; Frank Giles
Laromustine (cloretazine).
Expert opinion on pharmacotherapy 2010;11(4):657-67.
2010: Hugues de Lavallade; Pascal Finetti; Nadine Carbuccia; Jamshid Sorouri Khorashad; Aude Charbonnier; Letizia Foroni; Jane F Apperley; Norbert Vey; François Bertucci; Daniel Birnbaum; Marie-Joëlle Mozziconacci
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia.
Leukemia research 2010;34(2):254-7.
2010: Julien Rocquain; Nadine Carbuccia; Virginie Trouplin; Stéphane Raynaud; Anne Murati; Meyer Nezri; Zoulika Tadrist; Sylviane Olschwang; Norbert Vey; Daniel Birnbaum; Véronique Gelsi-Boyer; Marie-Joëlle Mozziconacci
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
BMC cancer 2010;10():401.
2010: Thomas Prébet; Patrick Ladaique; Martin Ferrando; Christian Chabannon; Catherine Faucher; Hugues de Lavallade; Jean El-Cheikh; Sabine Furst; Norbert Vey; Anne-Marie Stoppa; Patrice Viens; Didier Blaise; Mohamad Mohty
Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.
Experimental hematology 2010;38(1):55-60.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Marion Ciudad; Cindy Racoeur; Valérie Jooste; Norbert Vey; Bruno Quesnel; Pierre Fenaux; Jean-Noël Bastie; Odile Beyne-Rauzy; Aspasia Stamatoulas; François Dreyfus; Norbert Ifrah; Stéphane de Botton; William Vainchenker; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay; Eric Solary
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Haematologica 2009;94(12):1676-81.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Meyling Cheok; Sophie Grabar; Véronique Della Valle; Françoise Picard; Franck Viguié; Bruno Quesnel; Odile Beyne-Rauzy; Eric Solary; Norbert Vey; Mathilde Hunault-Berger; Pierre Fenaux; Véronique Mansat-De Mas; Eric Delabesse; Philippe Guardiola; Catherine Lacombe; William Vainchenker; Claude Preudhomme; François Dreyfus; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Blood 2009;114(15):3285-91.
2009: Thomas Prébet; Nicolas Boissel; Sarah Reutenauer; Xavier Thomas; Jacques Delaunay; Jean-Yves Cahn; Arnaud Pigneux; Bruno Quesnel; Francis Witz; Sylvain Thépot; Valérie Ugo; Christine Terre; Christian Recher; Emmanuelle Tavernier; Mathilde Hunault; Benjamin Esterni; Sylvie Castaigne; françois guilhot; Hervé Dombret; Norbert Vey
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4747-53.
2009: Jérôme Rey; Caroline Veuillen; Norbert Vey; Réda Bouabdallah; Daniel Olive
Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors.
Trends in molecular medicine 2009;15(6):275-84.
2009: Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Julien Bonansea; Nathalie Cervera; Nadine Carbuccia; Arnaud Lagarde; Thomas Prebet; Meyer Nezri; Danielle Sainty; Sylviane Olschwang; Luc Xerri; Max Chaffanet; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
British journal of haematology 2009;145(6):788-800.
2009: Lionel Adès; Simone Boehrer; Thomas Prebet; Odile Beyne-Rauzy; Laurence Legros; Christophe Ravoet; François Dreyfus; Aspasia Stamatoullas; Marie Pierre Chaury; Jacques Delaunay; Guy Laurent; Norbert Vey; Sara Burcheri; Rose-Marie Mbida; Natacha Hoarau; Claude Gardin; Pierre Fenaux
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
Blood 2009;113(17):3947-52.
2009: J Tamburini; C Elie; Sophie Park; Odile Beyne-Rauzy; Martine Gardembas; Christian Berthou; Béatrice Mahe; L Sanhes; Aspasia Stamatoullas; Norbert Vey; Achille Aouba; B Slama; B Quesnel; A Vekhoff; J J Sotto; Dominique Vassilief; C Al-Nawakil; Pierre Fenaux; François Dreyfus; Didier Bouscary
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
Leukemia research 2009;33(4):547-50.
2009: Thomas Prebet; Marie-Joëlle Mozziconacci; Danielle Sainty; Christine Arnoulet; Marina Lafage; Nicole Dastugue; Aude Charbonnier; Diane Coso; Jean-Albert Gastaut; Didier Blaise; Norbert Vey
Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.
Leukemia & lymphoma 2009;50(3):485-7.
2008: Oumedaly Reman; Arnaud Pigneux; Francoise Huguet; Norbert Vey; André Delannoy; Nathalie Fegueux; Stéphane de Botton; Aspasia Stamatoullas; Olivier Tournilhac; Agnès Buzyn; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Jean-Paul Vernant; Denis Fière; Hervé Dombret; Xavier Thomas
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Leukemia research 2008;32(11):1741-50.
2008: Marie-Joëlle Mozziconacci; Nadine Carbuccia; Thomas Prebet; Aude Charbonnier; Anne Murati; Norbert Vey; Max Chaffanet; Daniel Birnbaum
Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
Leukemia research 2008;32(8):1304-8.
2008: Catherine Cordonnier; Mohamad Mohty; Catherine Faucher; Cécile Pautas; Marie Robin; Norbert Vey; Françoise Monchecourt; Lamine Mahi; Patricia Ribaud
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.
International journal of antimicrobial agents 2008;31(2):135-41.
2008: Sophie Park; Sophie Grabar; Charikleia Kelaidi; Odile Beyne-Rauzy; Françoise Picard; Valérie Bardet; Valérie Coiteux; Geneviève Leroux; Pascale Lepelley; Marie-Thérèse Daniel; Stéphane Cheze; Béatrice Mahé; Augustin Ferrant; C Ravoet; Martine Escoffre-Barbe; Lionel Adès; Norbert Vey; Lina Aljassem; Aspasia Stamatoullas; Lionel Mannone; Hervé Dombret; Keith Bourgeois; Peter Greenberg; Pierre Fenaux; François Dreyfus
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
Blood 2008;111(2):574-82.
2008: Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Nicola Aceto; Virginie Remy; Stephane Pinson; Claude Houdayer; Christine Arnoulet; Danielle Sainty; Mohamed Bentires-Alj; Sylviane Olschwang; Norbert Vey; Marie-Joëlle Mozziconacci; Daniel Birnbaum; Max Chaffanet
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.
BMC cancer 2008;8():299.
2007: Emmanuelle Tavernier; Quoc-Hung Le; Stéphane de Botton; Nathalie Dhédin; Claude-Eric Bulabois; Oumedaly Reman; Norbert Vey; Véronique Lhéritier; Hervé Dombret; Xavier Thomas
Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Cancer 2007;110(12):2747-55.
2007: Véronique Gelsi-Boyer; Nathalie Cervera; F Bertucci; V Trouplin; V Remy; Sylviane Olschwang; Max Chaffanet; Norbert Vey; Marie-Joëlle Mozziconacci; Daniel Birnbaum
Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes.
Leukemia 2007;21(11):2359-62.
2007: Arnaud Pigneux; Virginie Perreau; Eric Jourdan; Norbert Vey; Nicole Dastugue; Francoise Huguet; Jean-Jacques Sotto; L Rachid Salmi; Norbert Ifrah; Josy Reiffers
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
Haematologica 2007;92(10):1327-34.
2007: Emmanuelle Tavernier; Jean-Michel Boiron; Francoise Huguet; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Jean-Paul Vernant; Hervé Dombret; Xavier Thomas
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia 2007;21(9):1907-14.
2007: Didier Blaise; Norbert Vey; Catherine Faucher; Mohamad Mohty
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
Haematologica 2007;92(4):533-41.
2007: Anne Etienne; Benjamin Esterni; Aude Charbonnier; Marie-Joëlle Mozziconacci; Christine Arnoulet; Diane Coso; Brigitte Puig; Jean-Albert Gastaut; Dominique Maraninchi; Norbert Vey
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.
Cancer 2007;109(7):1376-83.
2007: Jean El-Cheikh; Catherine Faucher; Sabine Fürst; S Duran; P Berger; Norbert Vey; Anne-Marie Stoppa; Reda Bouabdallah; Jean-Albert Gastaut; Patrice Viens; Didier Blaise; Mohamad Mohty
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(5):301-6.
2006: Hugues de Lavallade; Mohamad Mohty; Jean El-Cheikh; Philippe A Cassier; Catherine Faucher; Sabine Fürst; Norbert Vey; Anne-Marie Stoppa; Danielle Sainty; Christine Arnoulet; Luc Xerri; Jean-Albert Gastaut; Didier Blaise; Reda Bouabdallah
Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma.
British journal of haematology 2006;135(3):408-10.
2006: Véronique Gelsi-Boyer; Norbert Vey
[Recent advances in the treatment of myelodysplastic syndromes].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2006;27(8):600-9.
2006: Norbert Vey; André Bosly; Agnès Guerci; Walter Feremans; Hervé Dombret; François Dreyfus; David Bowen; Alan Burnett; Mike Dennis; Vincent Ribrag; Nicole Casadevall; Laurence Legros; Pierre Fenaux
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2465-71.
2006: Anne Murati; José Adélaïde; Véronique Gelsi-Boyer; Anne Etienne; Virginie Rémy; H Fezoui; Danielle Sainty; Luc Xerri; Norbert Vey; Sylviane Olschwang; Daniel Birnbaum; Max Chaffanet; Marie-Joëlle Mozziconacci
t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera.
Leukemia 2006;20(6):1175-8.
2006: Hugues de Lavallade; Catherine Faucher; Sabine Fürst; Jean El-Cheikh; Norbert Vey; Diane Coso; Reda Bouabdallah; Anne-Marie Stoppa; Jean-Albert Gastaut; Didier Blaise; Mohamad Mohty
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
Bone marrow transplantation 2006;37(7):709-10.
2006: Norbert Vey; Francis Giles
Cloretazine for the treatment of acute myeloid leukemia.
Expert review of anticancer therapy 2006;6(3):321-8.
2006: Nathalie Dhédin; Hervé Dombret; Xavier Thomas; Véronique Lhéritier; Jean-Michel Boiron; Françoise Rigal-Huguet; Norbert Vey; Mathieu Kuentz; Oumedaly Reman; Francis Witz; André Delannoy; Tibor J Kovacsovics; Kenneth F Bradstock; Christiane Charrin; Claude Boucheix; Jean Gabert; Didier Blaise; Denis Fière; Jean-Paul Vernant
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials.
Leukemia 2006;20(2):336-44.
2005: Mohamad Mohty; Didier Blaise; Catherine Faucher; Norbert Vey; Reda Bouabdallah; Anne-Marie Stoppa; Frédéric Viret; Gwenaelle Gravis; Daniel Olive; Béatrice Gaugler
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.
Blood 2005;106(13):4407-11.
2005: Didier Blaise; Jean Michel Boiron; Catherine Faucher; Mohamad Mohty; Jacques-Olivier Bay; Valerie-Jeanne Bardoux; Virginie Perreau; Diane Coso; Arnaud Pigneux; Norbert Vey
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
Cancer 2005;104(9):1931-8.
2005: V Ivanov; Catherine Faucher; Mohamad Mohty; Karin Bilger; Patrick Ladaique; Danielle Sainty; Christine Arnoulet; Christian Chabannon; Norbert Vey; Jacques Camerlo; Reda Bouabdallah; Patrice Viens; Dominique Maraninchi; Valérie-Jeanne Bardou; Benjamin Esterni; Didier Blaise
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Bone marrow transplantation 2005;36(10):901-6.
2005: Eric Jourdan; Jean-Michel Boiron; Nicole Dastugue; Norbert Vey; Gérald Marit; Françoise Rigal-Huguet; Lysiane Molina; Nathalie Fegueux; Arnaud Pigneux; Christian Recher; Jean-François Rossi; Michel Attal; Jean-Jacques Sotto; Dominique Maraninchi; Josy Reiffers; Valérie-Jeanne Bardou; Benjamin Esterni; Didier Blaise
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7676-84.
2005: Youcef Chelghoum; Norbert Vey; Emmanuel Raffoux; Francoise Huguet; Arnaud Pigneux; Brigitte Witz; Cécile Pautas; Stéphane de Botton; Denis Guyotat; Bruno Lioure; Nathalie Fegueux; Frédéric Garban; Hussam Saad; Xavier Thomas
Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.
Cancer 2005;104(1):110-7.
2005: Anne Murati; Christine Arnoulet; Marina Lafage-Pochitaloff; José Adélaide; Martine Derré; Borhane Slama; Bénédicte Delaval; Cornel Popovici; Norbert Vey; Luc Xerri; Marie-Joëlle Mozziconacci; Olivier Boulat; Danielle Sainty; Daniel Birnbaum; Max Chaffanet
Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
International journal of oncology 2005;26(6):1485-92.
2005: Mohamad Mohty; Hugues de Lavallade; Patrick Ladaique; Catherine Faucher; Norbert Vey; Diane Coso; Anne-Marie Stoppa; Jean-Albert Gastaut; Didier Blaise
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.
Leukemia 2005;19(6):916-20.
2005: Eric Jourdan; Françoise Rigal-Huguet; Gérald Marit; Norbert Vey; Nicole Dastugue; Nathalie Fegueux; Lysiane Molina; Jean-Albert Gastaut; Laurence Legros; Hacene Zerazhi; Sylvie Cailleres; Frédéric Bauduer; Dominique Bordessoule; Michel Attal; Didier Blaise; Arnaud Pigneux
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
British journal of haematology 2005;129(3):403-10.
2005: Vahid Asnafi; Agnès Buzyn; Xavier Thomas; Francoise Huguet; Norbert Vey; Jean-Michel Boiron; Oumedaly Reman; Jean-Michel Cayuela; Veronique Lheritier; Jean-Paul Vernant; Denis Fiere; Elizabeth Macintyre; Hervé Dombret
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
Blood 2005;105(8):3072-8.
2005: Gandhi Damaj; Reda Bouabdallah; Norbert Vey; Karin Bilger; Mohamad Mohty; Jean-Albert Gastaut
Single-agent thalidomide induces response in T-cell lymphoma.
European journal of haematology 2005;74(2):169-71.
2004: Norbert Vey; Marie-Joëlle Mozziconacci; Agnès Groulet-Martinec; Stéphane Debono; Pascal Finetti; Nadine Carbuccia; Emmanuel Beillard; Elisabeth Devilard; Christine Arnoulet; Diane Coso; Danielle Sainty; Luc Xerri; Anne-Marie Stoppa; Marina Lafage-Pochitaloff; Catherine Nguyen; Rémi Houlgatte; Didier Blaise; Dominique Maraninchi; Françoise Birg; Daniel Birnbaum; François Bertucci
Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling.
Oncogene 2004;23(58):9381-91.
2004: FREDERIC COLLART; François Kerbaul; Gandhi Damaj; Christine Zandotti; Norbert Vey; Thierry Mesana; Annick Mouly-Bandini
Visceral Kaposi's sarcoma associated with human herpesvirus 8 seroconversion in a heart transplant recipient.
Transplantation proceedings 2004;36(10):3173-4.
2004: Gandhi Damaj; Mohamad Mohty; Norbert Vey; E Dincan; Reda Bouabdallah; Catherine Faucher; Anne-Marie Stoppa; Jean-Albert Gastaut
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.
European journal of haematology 2004;73(6):402-6.
2004: Mohamad Mohty; Sophie Bagattini; Christian Chabannon; Catherine Faucher; Valérie-Jeanne Bardou; Karin Bilger; Norbert Vey; Béatrice Gaugler; Anne-Marie Stoppa; Diane Coso; Patrick Ladaique; Daniel Olive; Patrice Viens; Didier Blaise
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Experimental hematology 2004;32(11):1097-102.
2004: Xavier Thomas; Jean-Michel Boiron; Francoise Huguet; Hervé Dombret; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Jean-Paul Vernant; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Denis Fiere
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4075-86.
2004: Mohamad Mohty; Hugues de Lavallade; Catherine Faucher; Karin Bilger; Norbert Vey; Anne-Marie Stoppa; Gwenaelle Gravis; Diane Coso; Patrice Viens; Jean-Albert Gastaut; Didier Blaise
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2004;34(6):527-30.
2004: Norbert Vey; Diane Coso; Valérie-Jeanne Bardou; Anne-Marie Stoppa; Anne-Chantal Braud; Reda Bouabdallah; Danielle Sainty; Marie-Joëlle Mozziconacci; Marina Lafage; Gandhi Damaj; Didier Blaise; Jean-Albert Gastaut; Dominique Maraninchi
The benefit of induction chemotherapy in patients age > or = 75 years.
Cancer 2004;101(2):325-31.
2004: Gandhi Damaj; Aude Charbonnier; Reda Bouabdallah; Norbert Vey; Diane Coso; Anne-Marie Stoppa; Jean-Albert Gastaut
Monoclonal antibodies and cytomegalovirus infections.
European journal of haematology 2004;73(1):73-4.
2004: Mohamad Mohty; Eric Jourdan; Naira Ben Mami; Norbert Vey; Gandhi Damaj; Didier Blaise; Daniel Isnardon; Daniel Olive; Béatrice Gaugler
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia.
Blood 2004;103(12):4666-8.
2004: Gandhi Damaj; V Ivanov; B Le Brigand; E D'incan; M F Doglio; Karin Bilger; Catherine Faucher; Norbert Vey; Jean-Albert Gastaut
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Annals of hematology 2004;83(6):390-3.
2004: V Ivanov; Catherine Faucher; Mohamad Mohty; Karin Bilger; Patrick Ladaique; Danielle Sainty; Christine Arnoulet; Christian Chabannon; Norbert Vey; Jacques Camerlo; Reda Bouabdallah; Dominique Maraninchi; Valérie-Jeanne Bardou; Didier Blaise
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Transfusion 2004;44(4):501-8.
2004: Norbert Vey; Reda Bouabdallah; Anne-Marie Stoppa; C Faucher; Marina Lafage; Christian Chabannon; Danielle Sainty; J Gastaut; Dominique Maraninchi; Didier Blaise
Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution.
Bone marrow transplantation 2004;33(2):177-82.
2003: V Ivanov; Catherine Faucher; Karin Bilger; Norbert Vey; Danielle Sainty; Boris Calmels; Christian Chabannon; Marina Lafage-Pochitaloff; Marie-Joëlle Mozziconacci; Mohamad Mohty; M A Chrestian; Didier Blaise
Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
Bone marrow transplantation 2003;32(9):961-3.
2003: Mohamad Mohty; W Jacot; Catherine Faucher; Jacques-Olivier Bay; Christine Zandotti; L Collet; Bachra Choufi; Karin Bilger; Olivier Tournilhac; Norbert Vey; Anne-Marie Stoppa; Diane Coso; Jean-Albert Gastaut; Patrice Viens; Dominique Maraninchi; Daniel Olive; Didier Blaise
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen.
Leukemia 2003;17(11):2168-77.
2003: Catherine Faucher; Mohamad Mohty; Norbert Vey; Béatrice Gaugler; Karin Bilger; Marie-Joelle Moziconnacci; Anne-Marie Stoppa; Diane Coso; Patrick Ladaique; Christian Chabannon; Denis Reviron; Dominique Maraninchi; Jean-Albert Gastaut; Daniel Olive; Didier Blaise
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
Experimental hematology 2003;31(10):873-80.
2003: Mohamad Mohty; Béatrice Gaugler; Boris Calmels; Didier Blaise; Norbert Vey; Christian Chabannon; Daniel Olive
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].
Bulletin du cancer 2003;90(8-9):751-7.
2003: Mohamad Mohty; Jacques-Olivier Bay; Catherine Faucher; Bachra Choufi; Karin Bilger; Olivier Tournilhac; Norbert Vey; Anne-Marie Stoppa; Diane Coso; Christian Chabannon; Patrice Viens; Dominique Maraninchi; Didier Blaise
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Blood 2003;102(2):470-6.
2003: Jacques Delaunay; Norbert Vey; Thierry Leblanc; Pierre Fenaux; Françoise Rigal-Huguet; Francis Witz; Thierry Lamy; Anne Auvrignon; Didier Blaise; Arnaud Pigneux; Francine Mugneret; Christian Bastard; Nicole Dastugue; Jacqueline van den Akker; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Hervé Dombret
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Blood 2003;102(2):462-9.
2003: Christian Chabannon; Anne-Gaelle Le Corroller; Frédéric Viret; C Eillen; Catherine Faucher; Jean-Paul Moatti; Patrice Viens; Norbert Vey; Anne-Chantal Braud; G Novakovitch; Patrick Ladaique; Anne-Marie Stoppa; Jacques Camerlo; Dominique Genre; Dominique Maraninchi; Didier Blaise
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Leukemia 2003;17(4):811-3.
2002: Mohamad Mohty; Daniel Isnardon; Norbert Vey; Francine Brière; Didier Blaise; Daniel Olive; Béatrice Gaugler
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitors.
British journal of haematology 2002;119(1):115-8.
2002: Mohamad Mohty; Catherine Faucher; Norbert Vey; Christian Chabannon; Danielle Sainty; Christine Arnoulet; Béatrice Gaugler; Jean-Albert Gastaut; Dominique Maraninchi; Daniel Olive; Didier Blaise
Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis.
Leukemia 2002;16(10):2129-33.
2002: Mohamad Mohty; Béatrice Gaugler; Catherine Faucher; Danielle Sainty; Marina Lafage-Pochitaloff; Norbert Vey; Reda Bouabdallah; Christine Arnoulet; Jean-Albert Gastaut; Frédéric Viret; J Wolfers; Dominique Maraninchi; Didier Blaise; D Olive
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):157-64.
2002: Claude BAGNIS; Christian Chabannon; Gwenaelle Gravis; Anne-Marie Imbert; Christine Maroc; Florence Bardin; Patrick Ladaique; Frédéric Viret; Dominique Genre; Catherine Faucher; Anne-Marie Stoppa; Norbert Vey; Didier Blaise; Dominique Maraninchi; Patrice Viens; Patrice Mannoni
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.
Experimental hematology 2002;30(2):108-15.
2001: Mohamad Mohty; Catherine Faucher; Béatrice Gaugler; Norbert Vey; Danielle Sainty; Christine Arnoulet; Marie-Joëlle Mozziconacci; Daniel Isnardon; Jean-Albert Gastaut; Dominique Maraninchi; Daniel Olive; Didier Blaise
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report.
Bone marrow transplantation 2001;28(12):1157-60.
2001: Norbert Vey; G Balatzentko; Marina Lafage; Danielle Sainty; Reda Bouabdallah; Christian Chabannon; Didier Blaise; Jean-Albert Gastaut; Jean Gabert
Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia.
Leukemia & lymphoma 2001;42(5):945-52.
2001: Norbert Vey; Jacques Camerlo; Luc Xerri; N Petit; S Dermeche; Dominique Maraninchi
Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia.
Leukemia & lymphoma 2001;41(3-4):425-8.
2000: Gwenaelle Gravis; P Viens; Norbert Vey; D Blaise; Anne-Marie Stoppa; D Olive; D Maraninchi
Pilot study of immunotherapy with interleukin-2 after autologous stem cell transplantation in advanced breast cancers.
Anticancer research 2000;20(5C):3987-91.
2000: Mohamad Mohty; Catherine Faucher; Norbert Vey; Anne-Marie Stoppa; Frédéric Viret; I Chabbert; Christian Chabannon; Reda Bouabdallah; Patrick Ladaique; L Collet; Christine Zandotti; Dominique Maraninchi; Didier Blaise
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation.
Bone marrow transplantation 2000;26(3):251-5.
2000: Mohamad Mohty; Catherine Faucher; Christian Chabannon; Norbert Vey; Anne-Marie Stoppa; Patrick Ladaique; G Novakovitch; S Olivero; Reda Bouabdallah; Jean-Albert Gastaut; Dominique Maraninchi; Didier Blaise
CD34(+) immunoselected cells for poor graft function following allogeneic BMT.
Cytotherapy 2000;2(5):367-70.
1999: Norbert Vey; Didier Blaise; Marina Lafage; D Olive; Patrice Viens; D Baume; Jacques Camerlo; Anne-Marie Stoppa; R Gabus; M Brandely; T Hercend; Dominique Maraninchi
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(2):175-81.
1999: Frédéric Viret; Didier Blaise; Reda Bouabdallah; Anne-Marie Stoppa; G Novakovitch; Catherine Faucher; Norbert Vey; Jacques Camerlo; S Oziel-Taieb; Patrick Ladaique; Jean-Albert Gastaut; Dominique Maraninchi; Christian Chabannon
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement.
Hematology and cell therapy 1999;41(1):5-11.
1998: Dominique Maraninchi; Norbert Vey; Patrice Viens; Anne-Marie Stoppa; Eric Archimbaud; Michel Attal; D Baume; Reda Bouabdallah; F Demeoq; J Fleury; Mauricette Michallet; D Olive; Josy Reiffers; Danielle Sainty; A Tabilio; P Tiberghien; M Brandely; T Hercend; Didier Blaise
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
Leukemia & lymphoma 1998;31(3-4):343-9.
1998: S Oddou; Norbert Vey; Patrice Viens; Valérie-Jeanne Bardou; Catherine Faucher; Anne-Marie Stoppa; Christian Chabannon; Jacques Camerlo; Reda Bouabdallah; Jean-Albert Gastaut; Dominique Maraninchi; Didier Blaise
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Leukemia & lymphoma 1998;31(1-2):187-94.
1997: Norbert Vey; Patrice Viens; Chantal Fossat; D Olive; Danielle Sainty; D Baume; Anne-Marie Stoppa; Reda Bouabdallah; M Brandely; J A Gastaut; Dominique Maraninchi; Didier Blaise
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
European cytokine network 1997;8(4):389-94.
1997: Anne-Marie Stoppa; Reda Bouabdallah; Christian Chabannon; G Novakovitch; Norbert Vey; Jacques Camerlo; Didier Blaise; Luc Xerri; Michel Resbeut; D Di Stefano; Valérie-Jeanne Bardou; Jean-Albert Gastaut; Dominique Maraninchi
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1722-9.
1996: Catherine Faucher; Anne-Gaelle Le Corroller; Christian Chabannon; Patrice Viens; Anne-Marie Stoppa; Reda Bouabdallah; Jacques Camerlo; Norbert Vey; Gwenaelle Gravis; Jean-Albert Gastaut; G Novakovitch; Patrice Mannoni; Valérie-Jeanne Bardou; J P Moatti; Dominique Maraninchi; Didier Blaise
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Journal of hematotherapy 1996;5(6):663-70.
1996: Norbert Vey; B De Prijck; Catherine Faucher; Anne-Marie Stoppa; Danielle Sainty; Marina Lafage; Reda Bouabdallah; Christian Chabannon; Jacques Camerlo; Jean-Albert Gastaut; Dominique Maraninchi; Didier Blaise
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies.
Bone marrow transplantation 1996;18(3):495-9.
1996: Anne-Marie Stoppa; Norbert Vey; Danielle Sainty; Christine Arnoulet; Jacques Camerlo; M A Cappiello; Jean-Albert Gastaut; Dominique Maraninchi
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration.
British journal of haematology 1996;93(1):42-4.
1996: Norbert Vey; Didier Blaise; Pierre Tiberghien; Michel Attal; José-Luis Pico; Josy Reiffers; J L Harrousseau; D Fiere; A Tabilio; R Gabus; M Brandely; Dominique Maraninchi
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas.
Leukemia & lymphoma 1996;21(1-2):107-14.
1994: Norbert Vey; S Molnar; Catherine Faucher; Anne-Gaelle Le Corroller; Anne-Marie Stoppa; Patrice Viens; Reda Bouabdallah; Jacques Camerlo; G Novakovitch; Patrice Mannoni
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.
Bone marrow transplantation 1994;14(5):779-82.
1994: Norbert Vey; Didier Blaise; Anne-Marie Stoppa; Reda Bouabdallah; Marina Lafage; Danielle Sainty; Didier Cowen; Patrice Viens; G Lepeu; A P Blanc
Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
Bone marrow transplantation 1994;14(3):383-8.